Transfer of large DNA constructs in gene therapy studies is being recognised for its importance in maintaining the natural genomic environment of the gene of interest and providing tissue-specific regulation and control. However, methods used to deliver such constructs have been poorly studied. We used a receptor-mediated, integrin-targeting transfection system enhanced by liposomes, to deliver a 110 kb PAC (P1-based artificial chromosome) to HaCaT keratinocytes. The PAC contained the collagen VII locus, an EGFP (enhanced green fluorescent protein) reporter gene and the puromycin resistance gene (pac) to allow selection of stably transfected cells. Analysis of puromycin resistant and EGFPKeywords: integrin-targeting peptide; PAC; genomic DNA transfer; HaCaT keratinocytes; gene therapy Methods of DNA transfer used in current gene therapy projects are still biased towards viral vectors and their delivery of cDNA. However, such systems necessitate the use of heterologous promoters and exclude the native genomic environment of the gene which may include enhancers and control elements for tissue-specific regulation.
expressing colonies by Western blot showed that collagen VII production increased dramatically after transfection, indicating successful transfer of a large fully functional genomic locus. Fluorescent in situ hybridisation (FISH) and Southern blot analysis revealed that the PAC had integrated as at least one copy per cell. EGFP expression has persisted for 35 weeks, suggesting stable transgene expression. We conclude that the integrin-targeting peptide method of gene delivery is an effective means of stably delivering large DNA constructs to human keratinocytes and could be of benefit for genomic gene therapy approaches. Gene Therapy (2000) 7, 1600-1605.
tail. The transfection efficiency is enhanced by the incorporation of Lipofectin (L), a cationic liposome, into the DNA (D)-peptide (I) complex, creating the LID vector complex. This is thought to result in reduction of the endosomal degradation of DNA, 6 a known cause of low transfection efficiencies by methods which utilise the endocytotic pathway (discussed in Ref. 7) . Until now, however, this method has not been studied for transfer of large DNA constructs, or for its ability to transfect human keratinocytes.
Keratinocytes are the main cell type found in the epidermis and, as such, are of particular interest in gene therapy studies involving skin diseases. Targeting of the epidermis by gene transfer is a well-documented (reviewed in Ref. 8 ) and successful 9 means of potentially achieving long-term treatment of diseases such as epidermolysis bullosa (EB), a group of severe inherited skin disorders characterised by blistering and skin fragility after mechanical trauma. 10 HaCaT cells, a spontaneously immortalised keratinocyte cell line 11 have been used as a model in gene therapy for primary keratinocytes. They have been shown to tolerate transfection and selection more readily than primary cultures, while maintaining the ability to form stratified epithelia suitable for grafting. 12 We are developing methods of transfer of large genomic fragments into human keratinocytes containing entire loci of interest. In this study, we used HaCaT cells as a model to investigate the ability of the integrin-targeting peptide delivery system to transfer the entire COL7A1 locus within a PAC vector (P1-based artificial chromosomes). 13 The 32 kb COL7A1 encodes collagen VII, a major component of anchoring fibrils, which secure the epidermis to the dermis. Patients with the recessive dystrophic form of EB carry two mutated alleles of COL7A1; successful delivery of one functional allele to patient cells would suffice to restore collagen VII production to normal.
We report stable integration of the 110 kb PAC as assessed by fluorescent in situ hybridisation (FISH) and Southern blot analysis, and show an increase in collagen VII production after transfection, indicative of the transfer of a full-size functional genomic locus. We also document the long-term expression of reporter and antibiotic resistance genes.
A human PAC clone containing COL7A1 within a 170 kb insert (Figure 1a) was screened for the absence of gross deletions by PCR amplification of all COL7A1 exons. The PAC was then shortened by 84 kb and retrofitted as described 14 with a NotI-ended expression cassette taken from plasmid pPBKG (Figure 1b) , in order to construct PAC 46dP (Figure 1c ). The cassette in pPBKG contains the EGFP (enhanced green fluorescent protein) reporter gene under the control of the keratin 14 (K14) promoter. The merits of using the K14 promoter to drive expression of transgenes in keratinocytes have recently been shown 15 and include specific expression and regulation in basal cells of the epidermis. The plasmid also contains the pac gene (puromycin acetyltransferase) under the control of the SV40 promoter for mammalian resistance to puromycin and the bla gene (␤-lactamase) for bacterial resistance to ampicillin.
Microgram quantities of PAC DNA were prepared for transfection using Qiagen midi plasmid columns (Qiagen, Crawley, UK), with several modifications for purification of large low-copy number DNA vectors. Briefly, E. coli cultures were carried out in 400 ml terrific broth 16 for 14-16 h. The volumes of the alkaline lysis buffers used were increased from those recommended by Qiagen to improve lysis of cells. Additional centrifugation and filtering of the cleared lysate was performed to prevent blockage of the columns arising from the large number of E. coli cells being lysed. Before use in transfections, the DNA quality and concentration were assessed by NotI digestion and pulsed-field gel electrophoresis.
Cells were seeded at a density of 1 (8 kb) in MRC5 fibroblasts and primary fibroblasts using these products was of a reasonably high efficiency (5-15%), transfection of PACs (Ͼ120kb) resulted in a reduction of efficiency to Ͻ0.5% (data not shown). Similarly, the efficiency of transfection of small plasmids into HaCaT cells using these methods was no more than 2-Gene Therapy 3%, while we were unable to transfect large constructs into HaCaT cells (efficiency 0.5%).
HaCaT cells were grown in keratinocyte serum-free medium (Life Technologies) supplemented with epidermal growth factor and bovine pituitary extract. The cultures were maintained at 37°C in a humidified incubator with 6% CO 2 . MRC5 fibroblasts and primary fibroblasts were maintained in Dulbecco's modified Eagle's medium (DMEM) (Sigma, Poole, UK) supplemented with 10% FCS (Life Technologies), penicillin (100 U/ml), streptomycin (100 g/ml) and l-glutamine (4 mm).
We then compared lipofection with the LID vector as previously described 6 with some modifications. A total of 16 g of plasmid or PAC DNA (D) as four aliquots of 4 g was mixed with NaCl to give a final salt concentration of 100 mm. We had previously found that including NaCl in the transfection complex increased transfection efficiencies, as estimated by expression of EGFP, and that a transfection complex containing more than 4-5 g DNA would precipitate on mixing with the peptide. Four separate premixes were made with Lipofectin (L) followed by peptide 6 (I) (sequence (K) 16 GACRRE TAWACG), which specifically targets ␣5␤1 integrins. 6 After gentle mixing, the DNA-NaCl mix was added to the peptide/Lipofectin mixture and incubated at room temperature for 2 h. This order for the mixing of transfection medium components was strictly adhered to. 6 The L:I:D weight ratio was 0.75:6:1, which we had previously found to be optimal for transfection of MRC5 cells. OptiMem serum-free medium (Life Technologies) was added to the transfection complex to make up the desired volume (2 ml per premix). Culture medium was removed from the cells and the four transfection mixes were added dropwise while swirling the dish. After a 5 h incubation at 37°C, the transfection mix was removed from the cells and replaced with usual growth medium, then returned to the incubator for a further 19-31 h, after which transfection efficiency was assessed as percentage of cells expressing EGFP in several fields of view using a Nikon Diaphot 300 fluorescence microscope.
The use of the integrin-targeting peptide in association with either Lipofectin or Tfx-20 was found to increase significantly the transfection efficiency of both small plasmids and PACs into MRC5 fibroblasts to approximately 25% and 1-2%, respectively, in comparison with the use of lipid alone. More importantly, EGFP expression from transfection of both small plasmids and large PACs into HaCaT cells increased to approximately 20% and 0.5-1%, respectively. Although this latter figure remains low, expression of EGFP was seen to persist for longer after transfection using the integrin-targeting peptide/lipid method than using lipid alone; indeed, we have documented continuous expression over at least 35 weeks.
HaCaT cells transfected with PAC 46dP using the integrin-targeting peptide method were used in all further studies. Puromycin selection (2 g/ml) was applied and the cells were allowed to grow as pools for several weeks under a regime of alternating puromycin selection followed by relaxation of selection. Two separate populations of cells were analysed in all subsequent experiments. EGFP expression of population 2 was initially high but decreased to background levels after 6 weeks of continuous culture. By contrast, EGFP expression from population 1 remained at a high level for at least 35 weeks. A second integrin-targeting peptide (peptide 1, sequence (K) 16 GACRGDMFGCA) 6 with a nonspecific RGD motif was also used in association with cationic lipids to transfect HaCaT cells with PACs and small plasmids. However, the percentage of cells expressing EGFP after transfection was lower ( 0.5%) using this peptide than peptide 6.
Figure 1 Construction of the PAC construct. (a) The human PAC clone containing COL7A1 within a 170 kb insert was isolated by PCR screening of a human PAC library (P de Jong, Roswell Park Institute, Buffalo, NY, USA). Partial BssHII digestion (New England
After replating at a low density, transfected cells were observed to form colonies and reach confluency at the same rate as nontransfected HaCaT cells. Their phenotype also appeared identical after transfection. It therefore appears that our transfection method has little adverse effect on the growth potential or differentiation state of HaCaT cells. By contrast, some viral vectors, notably wild-type AAV, have been found to cause HaCaT cell differentiation. 17 After 12 weeks of continuous culture, both populations of HaCaT cells were harvested and metaphase chromosome spreads were prepared by conventional methods for analysis by FISH. Two probes were used to co-hybridise the metaphase chromosome spreads. The first was the original 186 kb PAC clone containing COL7A1, from which PAC 46dP was derived (Figure 1a) . The second was a plasmid similar to pPBKG but containing a CMV promoter rather than the K14 promoter upstream of EGFP, in order to avoid cross-hybridisation with keratin 14. The same metaphase chromosome spreads were also hybridised with a chromosome 3-specific paint probe in order to distinguish between endogenous and transgenic PAC hybridisation signals, as COL7A1 has been localised to chromosome 3p21. 18 Of the cells examined from population 2, a co-hybridised PAC and plasmid signal revealed that 68% had integrated the PAC construct, and 76% of these had done so with more than one copy per site, as determined by comparing the intensity of the hybridisation signal with was observed. As FISH is less sensitive when the probe and its genomic target are short DNA fragments, it is conceivable that detection of the cassette was not always achieved for this reason.
Analysis of metaphase spreads from each population was carried out to estimate the number of different integrative events within each population based on chromosome size, morphology and the position of integration 1 and 2) 29 within the chromosome. This revealed that within the 86% of transfected cells from population 1, the same integrative event had occurred, while population 2 contained cells from three separate stable integrations. Of the 68% transfected cells within population 2, 67% were shown to carry an integrative event in an acrocentric chromosome, 29% in a submetacentric chromosome and 4% in a metacentric chromosome. The intensity of all hybridisation signals in population 2 was stronger than the endogenous signal, with the exception of approximately half of the submetacentric chromosome signals which were of equal intensity to the endogenous.
Figure 3 Procollagen VII detection in transfected and untransfected HaCaT cells by immunoblot analysis. In two independent experiments (I and II) the approximate 320 kD pro-␣1(VII) polypeptide chain (arrowheads) was detected in cell lysates (a) and culture media (b) of untransfected HaCaT keratinocytes (CO) and in transfected HaCaT populations 1 and 2 (lanes
A quantitative comparison of copy number between the two populations was carried out using known standards of plasmid DNA (data not shown). Five micrograms of genomic DNA from populations 1 and 2 and nontransfected HaCaT cells was digested with NotI and loaded on a 1% agarose gel alongside a dilution series of quantified pPBKG DNA. A blot of the gel was hybridised using, as a probe, a 3 kb HindIII fragment of pPBKG (indicated in Figure 1b) . The intensity of the 7 kb band of expected size observed in each lane of transfected cell genomic DNA was calculated by Phosphorimager analysis (Molecular Dynamics, Cresham, UK). In a separate assay, the analysis was repeated using a PacI digest, and the intensity of the 30 kb band quantified (restriction sites are indicated in Figure 1 ). Based on an average of these assays, population 2 was estimated to carry four copies per cell, compatible with FISH analysis for the integrations in the acrocentric and metacentric chromosomes. In contrast, no specific signal could be seen from population 1, despite evidence from FISH analysis that cells had integrated the PAC at a low copy number per cell. This may be because the overall copy number is less than one per cell, as supported by FISH results documenting integration of the transgene in 86% of cells.
To assess the integrity of the transferred PAC construct, the NotI and PacI digests were repeated, loaded on a 1% agarose pulsed-field gel and electrophoresed for 14 h at 6 V/cm with a switch time of 2-15 s. A blot of the gel was hybridised with a 620 bp cDNA probe for the 3Ј end of COL7A1 (generated by RT-PCR amplification of exons 101-110). Analysis of the NotI-digested DNA revealed a band of 86 kb from population 2 corresponding to the entire genomic insert of PAC 46dP, in addition to the endogenous signal of 140 kb. Hybridisation to the PacI-digested DNA revealed a 45 kb band of expected size for the transgene, in addition to the endogenous band of 108 kb. As before, no obvious signal was detected in population 1. These data indicate that the entire 110 kb PAC 46dP has been transferred without breakage to cell population 2.
HaCaT cells from populations 1 and 2 were analysed by Western blot for the production of collagen VII. HaCaT cells which had not been transfected were used as a negative control. Densitometric analysis of the bands revealed that after transfection, cell lysates and media produced between 50 and 250% more collagen VII than before transfection (Figure 3) . The increase was particularly evident in the cell media, which is to be expected, since collagen VII is a secreted protein. These results strongly suggest that the collagen VII locus has been transferred to HaCaT cells in a functional form, and that the protein encoded by the transgene is correctly folded and eventually secreted into the media.
Interestingly, although population 1 expressed high levels of EGFP and population 2 much lower levels, falling to background after 6 weeks, there was no significant difference between collagen VII production between the two populations. This is based on an average of the results of several Western blots, only two of which are shown in Figure 3 . These results differ from previous reports which showed that multiple integrations can lead to silencing of the transgene. 19 We have demonstrated stable and efficient transfer of large pieces of genomic DNA to human epithelial cells using the LID vector. Our results suggest that the collagen VII locus contained within PAC 46dP is functional, has been transferred without breakage and that shortening of the genomic insert enables detectable levels of transgenic collagen VII to be produced.
The method of gene delivery which we used is of interest for gene therapy and functional studies of entire loci. To our knowledge, this technique has not previously been applied to large DNA constructs, or to transfection of keratinocytes, which are notoriously difficult to transfect. 20 Delivery of the transgene in its native genomic environment may overcome the problems of loss of gene expression which have been experienced after grafting retrovirally transduced keratinocytes. 21 While we have demonstrated that keratinocytes can be successfully transfected by this method, the specificity of delivery could be modified by targeting alternative integrins, enabling the study of tissue-specific gene regulation, or the transfer of genetic material to a particular cell type.
